143224-34-4

Basic information

• Product Name: Telinavir
• Synonyms: Telinavir;(2S)-N1-[(1S,2R)-3-[[[(1,1-Dimethylethyl)amino]carbonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]butanediamide;SC 52151
• CAS NO: 143224-34-4
• Molecular Formula: C33H44N6O5
• Molecular Weight: 604.748
• Product Categories: peptides
• Mol File: 143224-34-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 974.9°Cat760mmHg
• Flash Point: 543.4°C
• Appearance: /
• Density: 1.207g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.595
• CAS DataBase Reference: Telinavir(CAS DataBase Reference)
• NIST Chemistry Reference: Telinavir(143224-34-4)
• EPA Substance Registry System: Telinavir(143224-34-4)

Safety Data

• Hazardous Substances Data: 143224-34-4(Hazardous Substances Data)

Usage

Uses

Antiviral.

InChI:InChI=1/C33H44N6O5/c1-21(2)19-39(32(44)38-33(3,4)5)20-28(40)26(17-22-11-7-6-8-12-22)36-31(43)27(18-29(34)41)37-30(42)25-16-15-23-13-9-10-14-24(23)35-25/h6-16,21,26-28,40H,17-20H2,1-5H3,(H2,34,41)(H,36,43)(H,37,42)(H,38,44)/t26-,27-,28+/m0/s1

Upstream product

• 136465-99-1 2,5-dioxopyrrolidin-1-ylquinoline-2-carboxylate 
• 143224-65-1 {(S)-1-[(1S,2R)-1-Benzyl-3-(3-tert-butyl-1-isobutyl-ureido)-2-hydroxy-propylcarbamoyl]-2-carbamoyl-ethyl}-carbamic acid benzyl ester 
• 143224-64-0 N-<(3S-amino)-2R-hydroxy-4-phenylbutyl>-N'-(1,1-dimethylethyl)-N-(2-methyl-propyl)urea 
• 143224-63-9 [2(R),3(S)]-N-[[3-(phenylmethylcarbamoyl)amino-2-hydroxy-4-phenyl]-1-[(2-methylpropyl)]amino-2-(1,1-dimethyl)aminocarbonyl]butane 
• 143224-62-8 (2R,3S)-3-benzyloxycarbonylamino-2-hydroxy-1-(N-isobutylamino)-4-phenylbutane 
• 128018-43-9 N-benzyloxycarbonyl-3(S)-amino-1-chloro-4-phenyl-2(S)-butanol 
• 26049-94-5 (S)-benzyl (4-chloro-3-oxo-1-phenylbutan-2-yl)carbamate 
• 128018-44-0 N-benzyloxycarbonyl-3(S)-amino-1,2(S)epoxy-4-phenylbutane 
• 143224-66-2 (S)-2-Amino-N¹-[(1S,2R)-1-benzyl-3-(3-tert-butyl-1-isobutyl-ureido)-2-hydroxy-propyl]-succinamide 
• 143616-96-0 {(S)-1-[(1S,2S)-1-Benzyl-3-(3-tert-butyl-1-isobutyl-ureido)-2-hydroxy-propylcarbamoyl]-2-carbamoyl-ethyl}-carbamic acid benzyl ester 
• 686706-81-0 1-((2S,3S)-3-Amino-2-hydroxy-4-phenyl-butyl)-3-tert-butyl-1-isobutyl-urea 
• 149302-10-3 [(1S,2S)-1-Benzyl-3-(3-tert-butyl-1-isobutyl-ureido)-2-hydroxy-propyl]-carbamic acid tert-butyl ester 
• 143225-31-4 (2S,3S)-3-[N-(tert-butyloxycarbonyl)amino]-1-(isobutylamino)-4-phenylbutan-2-ol 
• 98760-08-8 (2R,3S)-3-[N-(tert-butyloxycarbonyl)amino]-1,2-epoxy-4-phenylbutane 

Relevant articles and documents

Self-emulsifying drug delivery system

Oral pharmaceutical formulation which improves the bioavailability of pharmaceuticals which are substantially water and oil insoluble is disclosed. In addition to the pharmaceutical, the formulation includes an emulsifier, an oil and an solubilizer. Alter

Discovery of a Novel Class of Potent HIV-1 Protease Inhibitors Containing the (R)-(Hydroxyethyl)urea Isostere

-